I was at the meeting yesterday. It was short by SLA standards.
Peter S is a hard man, took the piss out a shareholder's email that threatened a class action against SLA if they didn't have Ropren sales by yesterday. He based his whole talk around the email..very funny ( some would say rude and arrogant)
Anyway , IMO SLA remains on track for significant revenues this fin year.
I came away convinced about this and will buy more.
They are building a major company.
Body language, what was said publicly and privately and what wasn't said all show me they will make it happen.
.
SLA Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held